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Objective: The aim of this study was to assess the level of salivary immunoglobulins and periodontal status in
smokers and non-smokers.
Materials and methods: Unstimulated saliva of 30 subjects (mean age 24.2 ± 3.5 years) who were smokers (test
group) and of 30 subjects (mean age 25.3 ± 3.8 years) who were non-smokers (control group) was collected and
centrifugated; IgA, IgG, and IgM were measured with the colorimetric immunoenzymatic method. Moreover, the
following periodontal clinical parameters were recorded for each subject: plaque index (PI), gingival index (GI),
probing depth (PD), and clinical attachment level (CAL).
Results: A significantly (p< 0.05) lower Ig level was observed in smoking patients (IgA: 20.0 ± 1.2 mg/dl; IgM:
19.5 ± 1.6 mg/dl; IgG: 8.1 ± 1.4 mg/dl) compared to levels in the non-smoking control group (IgA: 234.1 ± 65.2 mg/dl;
IgM: 121.0 ± 31.7 mg/dl; IgG: 1049.4 ± 102 mg/dl). In the test group, PI (2.2 ± 0.3), GI (2.4 ±0.5), PD (49.3 ± 9.2%),
and CAL (49.3 ± 4.6%) were higher (p< 0.05) than those observed in the control group (PI: 0.8 ± 0.4; GI: 0.7 ± 0.3;
PD: 10.6 ± 2.4%; CAL: 3.1 ± 0.8%).
Conclusion: Smoking subjects showed lower levels of salivary IgA, IgG, and IgM and a worse periodontal condition
than non-smoking subjects. On the base of our study, as smoking subjects also had lower levels of IgA, IgG, and IgM
in their saliva than non-smoking subjects, despite the fact that there is little evidence that the salivary Igs have a
protective action against periodontitis and that the whole saliva does not result in whole from the salivary glands, it
can be concluded that the deteriorated periodontal health conditions of these patients can be attributed in part to a
lowering of the host’s defense due to a decrease in the quantity of Igs in salivary fluid.Background
Immunoglobulins (Igs) are protein molecules produced
by special cells in organisms’ immune systems in response
to the presence of the penetration of external agents, such
as viruses, bacteria, protozoans, fungi, tumor cells, or tis-
sues that are recognized as foreign because of the pres-
ence of cell surface antigens [1]. The function of Igs is to
bind antigen molecules with specificity and, consequently,
target bound molecules, such as toxins and constituents
of micro-organisms and parasites, for inactivation and/or
elimination from the organism [2].
Five Ig classes have been distinguished: IgMs, which
are the first type of antibody that neonates can produce
in case of an infection; IgGs, which appear when the* Correspondence: simtecc@unich.it
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reproduction in any medium, provided the ororganism is exposed for the second time to a particular
antigen and provide protection against toxins and vi-
ruses; IgEs, which are produced after an allergic reaction
and function to protect the organism against parasite in-
fections; IgAs, which protect the organism against local
infections; and IgDs, which act as receptors for B lympho-
cyte antigens, although their role has not been completely
clarified yet [3].
Igs are also present in saliva, where they act to provide
protection of the oral cavity. In particular, IgAs, which
are produced by the plasma cells of the salivary glands,
are the most represented Ig type in salivary fluid and,
together with the action carried out by the subgingi-
val microflora, exert a protective action against the oral
bacteria [1,2].
It has been observed that cigarette smoking can alter
the salivary system by increasing salivary fluid, reducingtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Periodontal evaluation in the test group
(smokers) and in the control group (non-smokers)
Periodontal parameter Test group Control group P value
PI (mean ± SD) 2.2 ± 0.3 0.8 ± 0.4 < 0.05
GI (mean ± SD) 2.4 ±0.5 0.7 ± 0.3 < 0.05
PD (%) 49.3 ± 9.2 10.6 ± 2.4 < 0.05




CAL: clinical attachment level.
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nase, and acid phosphatase), and altering anti-oxidizing
enzymes (i.e. glutathione peroxidase) and immune sys-
tem function [4,5]. Hence, a reduction of the Igs con-
tained in saliva can represent an increased risk factor for
the host mucosa with respect to pathogenic microorgan-
isms, including periodontal pathogens [6]. Although bac-
teria are the main etiological factor in the appearance of
periodontal diseases, the individual’s response is a crucial
factor in his or her susceptibility to disease [7]. Smoking
can worsen one’s periodontal status by altering the de-
fenses through two different mechanisms: damaging the
host’s normal response in the neutralization of infections
and producing alterations that cause the destruction of
surrounding healthy periodontal tissues [8].
Salivary immunoglobulin levels in smoking patients
with periodontal disease have not yet been studied com-
prehensively in literature.
The purpose of this study was to evaluate whether
a decrease in the levels of immunoglobulins (IgA, IgG,
IgM) in smokers is related to a worsening of the parame-
ters of periodontal health.
Methods
Selection criteria of test patients and controls
A total of 60 patients were included in this pilot study.
A written consent was obtained from all patients for their
participation in the study. All of the procedures were car-
ried out in compliance with the Declaration of Helsinki.
This study was approved by the ethical committee.
All of the patients racially identified themselves as
Caucasian (white) and had their complete set of perma-
nent teeth. According to our anamnesis assessments, all
showed similar habits with regard to nutrition and oral
hygiene (use of manual toothbrush and toothpaste only,
twice a day, and no use of other hygiene tools such as
dental floss, an interdental brush, or mouthwash). The
exclusion criteria were as follows: systemic diseases;
chronic use of drugs that could alter periodontal condi-
tions; having received professional hygiene or periodon-
tal therapies in the 6 months preceding the screening;
orthodontic care in progress; or dental fractures with a
score higher than 1, according to the classification of
Ellis [9].
The test group was composed of 30 individuals (15
males and 15 females; mean age 24.2 ± 3.5 years) who
were smokers (≥20 cigarettes/day for the last 4 years or
longer). The young age of the participants is justified as
we wanted to investigate these patients for the presence
of early-onset periodontal disease.
The control group was composed of 30 individuals (15
males and 15 females; mean age 25.3 ± 3.8 years) who
were non-smokers (they declared they had never smoked
in their entire lives).Salivary analysis
A 16-ml sample of saliva (without stimulation and not
containing blood) was collected from each patient in a
sterile container.
The salivary samples were collected at the same hour
of the day (09:00 a.m. in the morning); moreover, for
each patient, two salivary samples were collected at a
distance of 1 week, and the average values were calcu-
lated between the two samples so as to partially reduce
the subjective variability.
Four 4-ml aliquots of each sample were transferred with
a plastic sterile syringe into separate centrifuge glass test
tubes. The saliva sample aliquots were centrifuged in
the laboratory for clinical analysis and the levels of
IgA, IgG, and IgM were measured using the colorime-
tric immunoenzymatic method (IBL International GMBH,
Germany) [10].
Periodontal analysis
The patients were examined in a standardized manner
by the same examiner who was blinded to the group as-
signments of the patients. For the clinical evaluation, we
used dental mirrors and a University of North Carolina
(UNC) periodontal probe (15 mm).
The clinical survey included the analysis of the follo-
wing parameters:
– Plaque index (PI): presence of bacterial plaque on
four surfaces of the tooth (distal, mesial, buccal, and
lingual) in correspondence with the cervical line. A
score from 0 (no plaque) to 3 (severe plaque
accumulation) was assigned to each surface, and the
means and standard deviations of all values were
calculated (Table 1).
– Gingival index (GI): measured on four surfaces of
the tooth (distal, mesial, buccal, and lingual) using a
UNC periodontal probe in the gingival area adjacent
to the teeth. A GI score from 0 (no gingival
inflammation) to 3 (severe inflammation) was
assigned, and the means and standard deviations of
all values were calculated (Table 1).
Table 2 Evaluation of salivary immunoglobulins in
the test group (smokers) and in the control group
(non-smokers)
Immunoglobulins Test group Control group P value
IgA (mg/dl) 20.0 ± 1.2 234.1 ± 65.2 < 0.05
IgM (mg/dl) 19.5 ± 1.6 121.0 ± 31.7 < 0.05
IgG (mg/dl) 8.1 ± 1.4 1049.4 ± 102 < 0.05
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the periodontal pocket to the gingival line using a
periodontal probe inserted parallel to the long axis
of each tooth, with a controlled pressure at mesial,
distal, buccal, and lingual sites. For each tooth,
we considered the greatest PD value measured
among the four that were taken and for each
subject. We calculated the percentage of sites
with a value ≥ 4 mm.
– Clinical attachment level (CAL): the distance
between the cemento-enamel junction and the
bottom of the gingival sulcus, measured with a UNC
periodontal probe inserted parallel to the long axis
of each tooth, with controlled pressure at four sites
(mesial, distal, buccal, and lingual). For each
tooth, we considered the largest CAL value
measured among the four that were taken and,
for each subject, the percent of sites with a
value > 3 mm were calculated, as the limit of
3 mm indicates unambiguously the presence or
absence of a periodontal pocket with clinical
periodontal attachment loss.Statistical analysis
The statistical analysis was performed using the SPSS 15.0
program. The periodontal clinical parameters were mea-
sured twice for each subject, with an inter-measurement
interval of 1 week, to calculate intra-examiner reliability,
and the mean value between the two measurements was
considered. For each measurement, we accepted Cronbach’s
alpha (α) ≥ 0.8 as indicative of good reliability.
For salivary Ig levels, plaque accumulation, and GI, we
assessed statistically significant differences between the
groups using Student’s t-test. We used the Chi-square
test to compare percent values for probing depth and
clinical attachment level data between the groups. The
level of significance was set at p < 0.05. The Pearson cor-
relation coefficient was calculated to highlight the inter-
linkages between the periodontal and salivary parameter
values.Results
Evaluation of salivary fluid
The salivary analysis revealed significantly lower Ig levels
in smoking patients compared to levels in the non-
smoking control group (Table 2). Specifically, IgA levels
were 20.0 ± 1.2 mg/dl in smoking patients and 234.1 ±
65.2 mg/dl in controls (p < 0.05). IgM levels were 19.5 ±
1.6 mg/dl in the test group versus 121.0 ± 31.7 mg/dl in
the control group (p < 0.05). Finally, IgG levels in smok-
ing patients were 8.1 ± 1.4 mg/dl, more than two degrees
of magnitude lower than levels measured in the control
group (1049.4 ± 102 mg/dl; p < 0.05).Periodontal evaluation
Analysis of the plaque accumulation findings revealed
that PI scores in the test group (2.2 ± 0.3) were higher
than those observed in the control group (0.8 ± 0.4;
p < 0.05) (Table 1). With respect to gingival inflammation,
smoking patients had higher GI scores (2.4 ± 0.5) than
non-smoking subjects (0.7 ± 0.3; p < 0.05).
The percentage of periodontal sites with PD pockets ≥
4 mm was higher (p < 0.05) in smoking patients (49.3 ±
9.2%) than in the non-smoking control group (10.6 ±
2.4%). Finally, our analysis of CAL revealed that smoking
patients had a higher percentage of sites > 3 mm high
(29.6 ± 4.6%), by almost ten-fold, than patients of the
control group (3.1 ± 0.8%; p < 0.05).
A statistically significant correlation was observed in
the test group, between each value of immunoglobulins
(IgA, IgM, IgG) and the examined periodontal parame-
ters (PI, GI, PD, CAL).
Discussion
At present, there is strong evidence that connects seve-
ral pathologies of the oral cavity with cigarette smoking,
whose possible effects on the mouth are manifold, in-
cluding staining of natural teeth and restorations, black
hairy tongue, nicotinic stomatitis, and serious lesions
such as oral carcinoma [8,11]. In particular, the asso-
ciation between cigarette smoking and alcohol causes
an increase in the risk of occurrence of oral precancerous
lesions and cancer lesions, as alcohol is capable of dissolv-
ing some carcinogenic compounds present in tobacco
smoke, such as nitrosamines, and produces vasodilation,
which facilitates the absorption, by the mucosa, of the
toxic substances contained in the smoke [12].
Additionally, smoking can cause important alterations
in saliva because saliva is the first body fluid that comes
into contact with the gaseous phase of cigarette smoke.
Tobacco use has been shown to cause an immediate
stimulation of the salivary fluid. Although there are
no documented long-term effects of this stimulation
per se, reduced enzyme levels and buffering capacity
of the saliva relative to non-smoking patients has been re-
ported for smokers [4,13].
In this study, we detected decreased levels of IgA, IgG,
and IgM in the saliva of smoking subjects; these Igs
carry out a protective function against infections [2].
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hygiene habits, our smoking patients were in worse peri-
odontal condition than control patients, demonstrating
high levels of bacterial plaque, gingival inflammation,
and deep periodontal pockets [14].
The high percentage of PD (49.3%), together with the
presence of a lower percentage of CAL (29.6%) observed
in patients of the test group, is probably due, in part, not
only to the apical migration of the periodontal attach-
ment but also to migration, in some pseudopockets, of
the gingival margin in the coronal direction.
Cigarette components generate a thicker layer of bac-
terial plaque, which appears to be less easily removed by
patients, and maintain a chronic level of inflammation of
gingival tissues [15,16].
We also recorded a loss of periodontal clinical attach-
ment in our smoking subjects that represents an irre-
versible process which, if not adequately treated, can
lead to dental mobility and, ultimately, tooth loss due to
a lack of adequate periodontal support [17]. The gingival
inflammation process and periodontal destruction ob-
served in smokers can be connected not only to the pres-
ence of bacterial plaque and of periodontal pathogenic
species but also to decreases in the host’s defenses vis-à-
vis a decrease in saliva Igs [18-20]. In fact, cigarette
smoking can alter T-cell immunoregulation and B-cell
differentiation, generating a decrease in production of
Igs, which protect the oral mucosa against periodontal
pathogenic bacteria. A low level of salivary Igs can be
regarded as a risk factor for oral diseases, especially peri-
odontal diseases [21,22].
Wang et al. highlighted the interconnection between
periodontal disease and levels of antibodies, and in
particular, that the periodontal therapy is able to de-
termine a reduction of antibody titers of the serum
against periodontal bacteria, and an increase of the
antibody avidity [23].
Thus, in the presence of periodontitis, the body reacts
by producing antibodies against microorganisms that are
responsible for the infection; however, in the case of
smoking subjects, there is a reduced number of T-helper
lymphocytes that are essential for the functioning of B
lymphocytes and for the production of antibodies, for
which the final result is a decrease in the levels of
antibodies.
Decreased IgA levels in saliva are associated with an
increased degree of gingival inflammation [24]. The re-
sults of our study are aligned with those obtained by
Shilpashree, who highlighted a decrease in IgA in ci-
garette smokers [1]. Cigarette smoking is considered to
be a risk factor for the development of periodontal dis-
eases. Among the possible pathogenetic hypotheses, the
following have been considered: reduced function of gin-
gival fibroblasts, alteration of neutrophils, and alterationof the serum antibody response against pathogenic mi-
croorganisms [25].
The reduction of immunoglobulin levels could, in
some way, bind to the processes of development of pe-
riodontal lesions, although there are currently limited
evidence that the salivary Igs have a protective action
against periodontitis.
Furthermore, among the main limits of the study, there
is the small number of examined subjects.
The results and the considerations are to be consid-
ered as preliminary findings and further studies should
be conducted on a larger number of subjects in order to
confirm the details of this pilot study.
The smokers, being at risk of occurrence of various oral
diseases, should be monitored smoothly by a dentist.
In particular, a control of the state of periodontal health
by a periodontist at regular time intervals should be per-
formed, in order to keep under control the possible sites
of periodontal infection, and implement, in the case, the
required therapies.
Appropriate protocols of oral hygiene, at home and
professionally, appear therefore fundamental in main-
taining the health of the periodontium, even in patients
who smoke [25,26].
Conclusion
– In the smoking patients examined in this study, we
detected greater bacterial plaque levels, gingival
inflammation, probing depth, and loss of periodontal
clinical attachment than what was found in
non-smoking subjects.
– Smoking subjects also had lower levels of IgA, IgG,
and IgM in their saliva than non-smoking subjects.
– The deteriorated periodontal health conditions of
smoking patients can be attributed, in part, to a
lowering of the host’s defense due to a decrease in
the quantity of Igs in salivary fluid, despite the fact
that there is little evidence that the salivary Igs have
a protective action against periodontitis, and that
the whole saliva examined cannot result in toto from
the salivary glands.
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